Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention Among Women and Men
CORPS-CV
1 other identifier
observational
200
1 country
1
Brief Summary
The present research project aims to assess, through a survey, awareness of general and sex/gender-specific cardiovascular risk factors, as well as the perception of the risk of developing further cardiovascular diseases, among patients in secondary prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2026
CompletedFirst Posted
Study publicly available on registry
April 9, 2026
CompletedStudy Start
First participant enrolled
April 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 10, 2027
April 29, 2026
April 1, 2026
9 months
April 3, 2026
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Awareness of cardiovascular risk factors
Mean cardiovascular risk factor knowledge score, defined as the total number of correctly identified cardiovascular risk factors.
At enrollment
Self-reported risk perception of CVD
Defined as percentage of categorical variables (low, medium, high)
At enrollment
Self-reported comparative risk perception
Individual subjective evaluation of their own risk relative to a reference group (individuals of the same age and of the same or opposite biological sex), measured as a categorical variable (lower/equal/higher/unknown) (Self-reported comparative risk perception).
At enrollment
Secondary Outcomes (3)
Differences among females and males in self-assessed risk perception
At enrollments
Differences among females and males in self-reported comparative risk perception
At enrollment
Comparisons between responders in primary and secondary prevention
At enrollment
Interventions
There is not an intervention
Eligibility Criteria
The study involves the recruitment of adult patients attending the cardiology outpatient clinics of the participating centers who meet the inclusion criteria. Participation will be voluntary and contingent upon the signing of informed consent. Patients will complete the questionnaire in a self-administered format, either on paper or digitally via their own device (smartphone or tablet), according to their preference.
You may qualify if:
- Male or female participants aged ≥ 18 years at the time of signing informed consent.
- Individuals with atherosclerotic cardiovascular disease (ASCVD), defined as at least one of the following:
- Ischemic heart disease (e.g., documented myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, or ≥50% coronary stenosis in at least two coronary territories);
- Cerebrovascular disease (e.g., documented ischemic stroke; transient ischemic attack, primary intracerebral hemorrhage, and subarachnoid hemorrhage are not qualifying conditions; carotid stenting or endarterectomy);
- Peripheral arterial disease (e.g., peripheral arterial intervention, stent placement, surgical revascularization, lower limb amputation due to obstructive disease, or intermittent claudication with ABI \<0.90 in the past 12 months);
- Atherosclerotic aortic disease (e.g., abdominal or descending thoracic aortic aneurysm).
- Signed informed consent.
You may not qualify if:
- Inability or difficulty in completing the questionnaires in Italian and/or functional illiteracy.
- History of or current severe psychiatric disorder that could compromise the reliability of questionnaire responses.
- Refusal or withdrawal of informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istituti Clinici Scientifici IRCCS Maugeri
Milan, Italy
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2026
First Posted
April 9, 2026
Study Start
April 10, 2026
Primary Completion (Estimated)
January 10, 2027
Study Completion (Estimated)
January 10, 2027
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share